Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Gross Profit (2019 - 2025)

Biodesix's Gross Profit history spans 7 years, with the latest figure at $17.6 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 61.61% year-over-year to $17.6 million; the TTM value through Dec 2025 reached $67.4 million, up 20.86%, while the annual FY2025 figure was $71.8 million, 28.75% up from the prior year.
  • Gross Profit reached $17.6 million in Q4 2025 per BDSX's latest filing, roughly flat from $17.7 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $17.7 million in Q3 2025 to a low of $3.3 million in Q1 2022.
  • Average Gross Profit over 5 years is $10.4 million, with a median of $10.5 million recorded in 2021.
  • Peak YoY movement for Gross Profit: surged 202.93% in 2021, then plummeted 68.89% in 2022.
  • A 5-year view of Gross Profit shows it stood at $4.7 million in 2021, then surged by 33.19% to $6.3 million in 2022, then soared by 79.24% to $11.3 million in 2023, then fell by 3.37% to $10.9 million in 2024, then soared by 61.61% to $17.6 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Gross Profit are $17.6 million (Q4 2025), $17.7 million (Q3 2025), and $16.0 million (Q2 2025).